Tourmaline Bio, Inc.
TRMLDelisted Oct 28, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827506
Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Tourmaline Bio, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 54 | 54 | 0 |
| Shares | 26.8M | 26.9M | +98.0K (+0.4%) |
| Value | $27.4M | $50.6M | +$23.3M (+84.9%) |
New holders (9)
Institutions that held Tourmaline Bio, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BML Capital Management, LLC | 1,929,484 | $3.63M | 3.14% |
| Western Standard LLC | 586,481 | $1.10M | 1.12% |
| Bank of Montreal | 15,963 | $30.6K | 0.00% |
| Bailard, Inc. | 14,773 | $27.8K | 0.00% |
| Susquehanna International Group, LLP | 14,397 | $27.1K | 0.00% |
| Jane Street Group, LLC | 11,668 | $21.9K | 0.00% |
| Wells Fargo & Company | 4,089 | $7.69K | 0.00% |
| The PNC Financial Services Group, Inc. | 2,018 | $3.79K | 0.00% |
| Nisa Investment Advisors, LLC | 72 | $0 | 0.00% |
Sold out (9)
Institutions that held Tourmaline Bio, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Caas Capital Management LP | 90,181 | $92.0K |
| Ergoteles LLC | 43,522 | $44.4K |
| Squarepoint Ops LLC | 28,084 | $28.6K |
| Chicago Partners Investment Group LLC | 14,834 | $26.2K |
| Virtu Financial LLC | 16,372 | $17.0K |
| State Board of Administration of Florida Retirement System | 14,260 | $14.5K |
| Credit Suisse AG | 1 | $1 |
| Rockefeller Capital Management L.P. | 67 | $0 |
| IFP Advisors, Inc | 5,465 | – |